Modified Retzius-sparing robot-assisted radical prostatectomy for cases with anterior tumor: a propensity score-matched analysis
Objective To compare the outcomes between a modified Retzius-sparing robot-assisted radical prostatectomy (mRS-RARP) technique and conventional robot-assisted radical prostatectomy (Con-RARP) technique for cases with anterior prostate cancer (PCa), especially positive surgical margin (PSM) rates and urinary continence (UC). Patients and methods We retrospectively included 193 mRS-RARP and 473 Con-RARP consecutively performed by a single surgeon for anterior PCa. Perioperative complications, pathology, and continence were compared after propensity score matching using 9 variables. Results After matching (n = 193 per group), PSM were not significantly different in the two groups (16.1% in mRS-RARP group vs. 15.0% in Con-RARP group, p = 0.779). The UC at catheter removal and at 1-month was significantly higher in the mRS-RARP (24.9% vs. 9.8%, p < 0.001; 29.0% vs. 13.5%, p < 0.001, respectively), but not at 3-, 6-, and 12-month follow-ups (p = 0.261, 0.832, and 0.683, respectively). Conclusion mRS-RARP seems to be an oncologically safe approach for patients with anterior PCa. Compared with the conventional approach, mRS-RARP approach shows benefits in the short-term postoperative UC recovery..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
World journal of urology - 42(2024), 1 vom: 20. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Qian, Jiajun [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
BKL: | |
---|---|
Themen: |
Anterior prostate cancer |
Anmerkungen: |
© The Author(s) 2024 |
---|
doi: |
10.1007/s00345-024-04807-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR055220657 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR055220657 | ||
003 | DE-627 | ||
005 | 20240321064645.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240321s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00345-024-04807-7 |2 doi | |
035 | |a (DE-627)SPR055220657 | ||
035 | |a (SPR)s00345-024-04807-7-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.88 |2 bkl | ||
100 | 1 | |a Qian, Jiajun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Modified Retzius-sparing robot-assisted radical prostatectomy for cases with anterior tumor: a propensity score-matched analysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2024 | ||
520 | |a Objective To compare the outcomes between a modified Retzius-sparing robot-assisted radical prostatectomy (mRS-RARP) technique and conventional robot-assisted radical prostatectomy (Con-RARP) technique for cases with anterior prostate cancer (PCa), especially positive surgical margin (PSM) rates and urinary continence (UC). Patients and methods We retrospectively included 193 mRS-RARP and 473 Con-RARP consecutively performed by a single surgeon for anterior PCa. Perioperative complications, pathology, and continence were compared after propensity score matching using 9 variables. Results After matching (n = 193 per group), PSM were not significantly different in the two groups (16.1% in mRS-RARP group vs. 15.0% in Con-RARP group, p = 0.779). The UC at catheter removal and at 1-month was significantly higher in the mRS-RARP (24.9% vs. 9.8%, p < 0.001; 29.0% vs. 13.5%, p < 0.001, respectively), but not at 3-, 6-, and 12-month follow-ups (p = 0.261, 0.832, and 0.683, respectively). Conclusion mRS-RARP seems to be an oncologically safe approach for patients with anterior PCa. Compared with the conventional approach, mRS-RARP approach shows benefits in the short-term postoperative UC recovery. | ||
650 | 4 | |a Modified |7 (dpeaa)DE-He213 | |
650 | 4 | |a Retzius-sparing |7 (dpeaa)DE-He213 | |
650 | 4 | |a Urinary continence |7 (dpeaa)DE-He213 | |
650 | 4 | |a Positive surgical margin |7 (dpeaa)DE-He213 | |
650 | 4 | |a Anterior prostate cancer |7 (dpeaa)DE-He213 | |
700 | 1 | |a Fu, Yao |4 aut | |
700 | 1 | |a Marra, Giancarlo |4 aut | |
700 | 1 | |a Zhang, Feifei |4 aut | |
700 | 1 | |a Wu, Xiao |4 aut | |
700 | 1 | |a Li, Danyan |4 aut | |
700 | 1 | |a Xu, Linfeng |4 aut | |
700 | 1 | |a Qiu, Xuefeng |4 aut | |
700 | 1 | |a Gan, Weidong |4 aut | |
700 | 1 | |a Guo, Hongqian |0 (orcid)0000-0002-3121-5157 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t World journal of urology |d Springer Berlin Heidelberg, 1983 |g 42(2024), 1 vom: 20. März |w (DE-627)SPR004296664 |w (DE-600)1463303-6 |x 1433-8726 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2024 |g number:1 |g day:20 |g month:03 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00345-024-04807-7 |z kostenfrei |3 Volltext |
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.88 |q VZ |
951 | |a AR | ||
952 | |d 42 |j 2024 |e 1 |b 20 |c 03 |